Showing results (191-200 of 3,522) with videos related to

Sort By:
Pageof 353
Thoracic Cancer|February 9, 2017
Factors associated with the diagnostic yield of computed tomography-guided transbronchial lung biopsySeon Cheol Park, Cheong Ju Kim, Chang Hoon Han, et al.
Thoracic Cancer|September 9, 2022
Retrospective analysis of independent predictors of progression-free survival in patients with EGFR mutation-positive advanced non-small cell lung cancer receiving first-line osimertinibShuhei Teranishi, Chihiro Sugimoto, Satoshi Nagaoka, et al.
Thoracic Cancer|September 2, 2022
Radial-EBUS and virtual bronchoscopy planner for peripheral lung cancer diagnosis: How it became the first-line endoscopic procedureSamy Lachkar, Loic Perrot, Diane Gervereau, et al.
Thoracic Cancer|September 2, 2022
Log odds of positive lymph nodes is a robust predictor of survival and benefits from postoperative radiotherapy in stage IIIA-N2 resected non-small cell lung cancerXing Jin, Donglai Chen, Yumei Shen, et al.
Thoracic Cancer|September 5, 2022
Post-progression survival after atezolizumab plus carboplatin and etoposide as first-line chemotherapy in small cell lung cancer has a significant impact on overall survivalKen Masubuchi, Hisao Imai, Satoshi Wasamoto, et al.
Thoracic Cancer|September 5, 2022
Large cell neuroendocrine carcinoma of the lung controlled for 4 years by a single administration of pembrolizumab: A case reportMasayuki Watanabe, Yuki Matsumura, Hikaru Yamaguchi, et al.
Thoracic Cancer|February 8, 2021
Predictive factors of recurrence after resection of subsolid clinical stage IA lung adenocarcinomaDong Jin Im, Sang Min Lee, Kyunghwa Han, et al.
Thoracic Cancer|February 10, 2021
Resistance mechanisms of epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer patients: A meta-analysisNobuaki Kobayashi, Seigo Katakura, Chisato Kamimaki, et al.
Thoracic Cancer|February 10, 2021
ALK-rearranged squamous cell carcinoma of the lungQiyi Meng, Yujie Dong, Hong Tao, et al.
Thoracic Cancer|February 16, 2021
Safety and efficacy of administering reduced doses of pegylated recombinant human granulocyte-colony stimulating factors in patients treated with cisplatin and etoposide for small cell carcinoma: A retrospective studyChang Liu, Ying Hao, Lei Wang, et al.
Pageof 353